Cite
Results of a 12-Month Randomized Controlled Trial Testing the Efficacy of the Diabetes Prevention Program Group Lifestyle Balance (DPP-GLB) for People Post Stroke (GLB-CVA).
MLA
Driver, Simon, et al. “Results of a 12-Month Randomized Controlled Trial Testing the Efficacy of the Diabetes Prevention Program Group Lifestyle Balance (DPP-GLB) for People Post Stroke (GLB-CVA).” Annals of Behavioral Medicine, vol. 57, no. 12, Dec. 2023, pp. 1032–45. EBSCOhost, https://doi.org/10.1093/abm/kaad045.
APA
Driver, S., McShan, E., Swank, C., Calhoun, S., Douglas, M., Suhalka, A., Bennett, M., Callender, L., Ochoa, C., Mukkamala, S., & Kramer, K. (2023). Results of a 12-Month Randomized Controlled Trial Testing the Efficacy of the Diabetes Prevention Program Group Lifestyle Balance (DPP-GLB) for People Post Stroke (GLB-CVA). Annals of Behavioral Medicine, 57(12), 1032–1045. https://doi.org/10.1093/abm/kaad045
Chicago
Driver, Simon, Evan McShan, Chad Swank, Stephanie Calhoun, Megan Douglas, Alexandria Suhalka, Monica Bennett, et al. 2023. “Results of a 12-Month Randomized Controlled Trial Testing the Efficacy of the Diabetes Prevention Program Group Lifestyle Balance (DPP-GLB) for People Post Stroke (GLB-CVA).” Annals of Behavioral Medicine 57 (12): 1032–45. doi:10.1093/abm/kaad045.